Insider trading: Doctors do it too
INSIDER trading is rife in the pharma industry and indiscreet doctors may be one of the reasons, say the authors of a new article.
They point to two main ways in which doctors are most likely to violate insider trading laws. They can share information about pending mergers and acquisitions when they sit on the boards of pharmaceutical or medical companies; or they can divulge inside knowledge about ongoing trials that could affect a company’s share price.
A high-profile case of the latter type is that of neurologist Sidney Galman at the University of Michigan, who told a hedge fund